These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17288763)

  • 1. [The relationship between TIMI (thrombolysis in myocardial infarction) risk score and efficacy of conservative or interventional strategy in patients with non-ST-segment elevation acute coronary syndromes].
    Zhao MZ; Hu DY; Ma CS; Jiang LQ; Huo Y; Zhu TG; Wang SW; Yan MY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):1001-4. PubMed ID: 17288763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The studies of risk factors and early intervention in patients with acute coronary syndromes without ST-segment elevation].
    Zhao MZ; Hu DY; Jiang LQ; Li TC; Ma CS; Jia SQ; Chen F; Yang M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):153-7. PubMed ID: 15924813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The changes of electrocardiogram and impact of early invasive strategy in patients with acute coronary syndromes without ST-segment elevation].
    Zhao MZ; Hu DY; Zhang FC; Wu Y; Yan MY; Wang SW; Mao JM; Yang M; Jiang LQ
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):879-82. PubMed ID: 16029524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between thrombolysis in myocardial infarction risk score and one-year outcomes for patients presenting at the emergency department with potential acute coronary syndrome.
    Weisenthal BM; Chang AM; Walsh KM; Collin MJ; Shofer FS; Hollander JE
    Am J Cardiol; 2010 Feb; 105(4):441-4. PubMed ID: 20152236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predict value of clinical risk score, thrombolysis in myocardial infarction flow grade and combined clinical risk score plus TIMI flow on outcome evaluation of patients with acute coronary syndrome].
    Zhong B; Liu ZZ; Su L; Lan XB; Chen YQ; Ling ZY; Yin YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):30-5. PubMed ID: 19099923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of early invasive strategy on early and late outcomes in high-risk non-ST-segment elevation acute coronary syndromes].
    Zhao MZ; Hu DY; Jiang LQ; Wu Y; Zhu TG; Hao HJ; Zhang LJ; Huo Y; Wang MS
    Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):737-40. PubMed ID: 16255878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18.
    Wylie JV; Murphy SA; Morrow DA; de Lemos JA; Antman EM; Cannon CP
    Am Heart J; 2004 Jul; 148(1):173-80. PubMed ID: 15215808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18.
    Kugelmass AD; Sadanandan S; Lakkis N; Dibattiste PM; Robertson DH; Demopoulos LA; Gibson CM; Weintraub WS; Murphy SA; Cannon CP;
    Crit Pathw Cardiol; 2006 Sep; 5(3):167-72. PubMed ID: 18340233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
    Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
    Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population.
    Pollack CV; Sites FD; Shofer FS; Sease KL; Hollander JE
    Acad Emerg Med; 2006 Jan; 13(1):13-8. PubMed ID: 16365321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TIMI risk score validation for patients with acute coronary syndrome without ST elevation].
    Bagur RH; Urinovsky FM; Contreras AE; Estrada CD
    Medicina (B Aires); 2009; 69(5):526-8. PubMed ID: 19897437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Thromb Haemost; 2005 Nov; 94(5):1077-83. PubMed ID: 16363252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
    Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.
    Morrow DA; Antman EM; Snapinn SM; McCabe CH; Theroux P; Braunwald E
    Eur Heart J; 2002 Feb; 23(3):223-9. PubMed ID: 11792137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score.
    Sanchis J; Bodí V; Núñez J; Bertomeu-González V; Gómez C; Bosch MJ; Consuegra L; Bosch X; Chorro FJ; Llàcer A
    J Am Coll Cardiol; 2005 Aug; 46(3):443-9. PubMed ID: 16053956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy.
    Herrmann HC; Murphy SA; Dibattiste PM; Delucca PT; Demopoulos LA; Gibson CM; Cannon CP
    Crit Pathw Cardiol; 2004 Jun; 3(2):95-100. PubMed ID: 18340148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.